For businesses, going green brings in greenbacks
Study finds manufacturers leading the drive to make sustainability a mainstream — and profitable — business practice.
Search Stories
MIT Sea Grant to host 15th annual Blue Lobster Bowl Feb. 4
One hundred twenty high school students to convene at MIT for the regional competition of the National Ocean Sciences Bowl
Robert Silbey, former MIT dean of science, dies at 71
'Excellent teacher' spent 45 years as faculty member, administrator.
New House Dining program off to a great start
Students report high satisfaction with quality, variety and service.
Pfizer expands its research footprint in Cambridge
Announces lease of space in building being developed by MIT
President Hockfield's charge to the graduates
'Our Great Dome travels with you, no matter where you stand on the face of the Earth.'
Five companies join the Center for Biomedical Innovation's NEWDIGS program
Bristol‐Myers Squibb, Johnson & Johnson, Life Technologies, Pfizer and Quintiles will support initiatives in regulatory science and oncology innovation.
Open for business
MIT Sloan School of Management officially dedicates new building, with an eye toward campus-wide collaboration and bringing innovations to society.
International biomedical imaging consortium convenes fellowship finalists
24 vying for inaugural Madrid–MIT M+Visión Consortium Fellowship in Biomedical Imaging.
Life on a dollar a day
In Poor Economics, Abhijit Banerjee and Esther Duflo open a window into the lives of the world’s poorest people, and suggest new remedies to combat poverty.
MIT selects Bon Appétit Management Co. as the House Dining vendor
Choice reflects input from Evaluation Committee, supports goals of dining program
Q&A with David Miliband on the war in Afghanistan
Former U.K. foreign secretary visiting MIT this week as a Wilhelm Fellow
New meal plan to offer more dietary options and flexibility
From athletes to vegetarians, kosher to vegan, revitalized House Dining program will broaden offerings for students.
A better way to target tumors
In spite of slow progress toward targeting cancer drugs to individual patients, hope remains.